MICHAEL KORNBERG: Open Payments
NPI 1174786834 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 31 payments from 8 companies in 2025. Trend: 2023 $1,287 · 2024 $1,335 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 8 | $203 |
| ABBVIE INC. | 5 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Supernus Pharmaceuticals, Inc. | 3 | $96 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Bausch Health US, LLC | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
Products named: REXULTI, VRAYLAR, TRINTELLIX, Qelbree, FANAPT, APLENZIN, Jornay PM.
Industry payments across CA — which companies pay providers there.
